This volume explores all aspects of vascular biochemistry and includes chapters that provide an understanding of vascular function with descriptions of tissue components present in the vascular wall as well as an exploration of the hemodynamic and metabolic activities associated with this function. In addition, some chapters explore the vasculature under conditions which mimic various disease states.
The information provided in this volume will provide new insights into the mechanisms that control vascular function as well as therapies designed to treat vascular disease.
Preface; P. Zahradka, J. Wigle, G.N. Pierce.
1. Osteoglycin expression and localization in rabbit tissues and atherosclerotic plaques; B. Fernández, et al.
2. Effects of midazolam on the contraction and relaxation of segments of thoracic aorta stripped of endothelium and stimulated by adrenaline - Experimental study in rabbits; A.A.F.R. Borges, O.M. Gomes.
3. Improved pulmonary artery buffering function during phenylephrine-induced pulmonary hypertension; D. Bia, et al.
4. Correlation between the extent of coronary atherosclerosis and lipid profile; J. Tarchalski, et al.
5. Regulation of cytosolic phospholipase A2 cyclooxygenase-1 and-2 expression by PMA, TNFalpha, LPS and M-CSF in human monocytes and macrophages; Y.J. Jiang, et al.
6. FR167653 suppresses the progression of experimental autoimmune myocarditis; S. Maruyama, et al.
7. The effect of early treatment by cervastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in patients with unstable angina and non-Q-wave myocardial infarction; P. Ostadal, et al.
8. Decreased activity of lecithin: cholesterol acyltransferase and hepatic lipase in chronic hypothyroid rats: implications for reverse cholesterol transport; M. Franco, et al.
9. Angiogenesis and myogeneis as two facets of inflammatory post-ischemic tissue regeneration; D. Scholz, et al.
10. Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells; G.X. Shen.
11. Effect of coenzyme Q10 on on risk of atherosclerosis in patients with recent myocardial infarction; R.B. Singh,et al.
12. Methodologic challenges in designing clinical studies to measure differences in the bioequivalence of n-3 fatty acids; D.H. Morris.
13. Dissemination of chlamydia pneumoniae to the vessel wall in atherosclerosis; S. Hirono, G.N. Pierce.
14. Bc110 protein can act as a transcription activator in yeast; M. Cheng, et al.
15. Activation of peroxisome proliferator-activated receptors alpha and gamma-1 inhibits human smoothe muscle cell proliferation; P. Zahradka, et al.
16. High levels of CUG-initiated FGF-2 expression cause chromatin compaction, decreased cardiomyocyte mitosis, and cell death; C.J.A. Hirst, et al.
17. In vitro effect of nicotine and cotinine on the susceptibility of LDL oxidation and hemoglobin glycosylation; S. Asgary, et al.
18. Plasma lipid and lipoprotein pattern in the Inuit of the Keewatin district of the Northwest Territories; M.J.B. Kutryk, B. Ramjiawan.
19. Effect of DHLA on response of isolated rat urinary bladder to repetitive field stimulation; R.M. Levin, et al.
20. Decreased level of 2,3-diphosphglycerate and alteration of structural integrity in erythrocytes infected with Plasmodium falciparum in vitro; M.L. Dubey, et al.
21. Aminosalicylic acid reduces the antiproliferative effect of hyperglycaemia, advanced glycation end products and glycated basic fibroblast growth factor in cultured bovine aortic endothelial cells: Comparison with aminoguanidine; Y. Duraisamy, et al.
22. High levels of palmitic acid lead to insulin resistance due to changes in the level of phosphorylation of the insulin receptor and insulin receptor substrate-1; R. Reynoso, e